Women’s Health Bulletin

Published by: Kowsar

Investigating Prognostic Factors for Assisted Reproductive Technology Outcomes in Qadir-Mother and Child Hospital of Shiraz, Iran

Ardeshir Bahmanimehr 1 , Bahia Namavar Jahromi 2 , 3 , * , Zahra Anvar 2 , 3 , * and Najmeh Moein-Vaziri 4
Authors Information
1 Thalassemia and Hemophilia Genetic, PND Research Center, Dastgheib Hospital, Shiraz University of Medical Sciences, Shiraz, Iran
2 Infertility Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
3 Department of Obstetrics and Gynecology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
4 IVF Center, Ghadir Mother and Child Hospital, Shiraz University of Medical Sciences, Shiraz, Iran
Corresponding Authors:
Article information
  • Women’s Health Bulletin: October 2018, 5 (4); e65058
  • Published Online: July 21, 2018
  • Article Type: Research Article
  • Received: December 12, 2017
  • Revised: June 30, 2018
  • Accepted: July 1, 2018
  • DOI: 10.5812/whb.65058

To Cite: Bahmanimehr A, Namavar Jahromi B, Anvar Z, Moein-Vaziri N. Investigating Prognostic Factors for Assisted Reproductive Technology Outcomes in Qadir-Mother and Child Hospital of Shiraz, Iran, Women Health Bull. 2018 ; 5(4):e65058. doi: 10.5812/whb.65058.

Abstract
Copyright © 2018, Women’s Health Bulletin. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. van Loendersloot LL, van Wely M, Repping S, van der Veen F, Bossuyt PM. Templeton prediction model underestimates IVF success in an external validation. Reprod Biomed Online. 2011;22(6):597-602. doi: 10.1016/j.rbmo.2011.02.012. [PubMed: 21493154].
  • 2. Minaretzis D, Harris D, Alper MM, Mortola JF, Berger MJ, Power D. Multivariate analysis of factors predictive of successful live births in in vitro fertilization (IVF) suggests strategies to improve IVF outcome. J Assist Reprod Genet. 1998;15(6):365-71. [PubMed: 9673880]. [PubMed Central: PMC3455016].
  • 3. Rowe PJ, Comhaire FH, Hargreave TB, Mahmoud AMA; World Health Organization. WHO Manual for the Standardized Investigation and Diagnosis of the Infertile Male. Cambridge University Press; 2000.
  • 4. Gnoth C, Godehardt E, Frank-Herrmann P, Friol K, Tigges J, Freundl G. Definition and prevalence of subfertility and infertility. Hum Reprod. 2005;20(5):1144-7. doi: 10.1093/humrep/deh870. [PubMed: 15802321].
  • 5. Rosen MP, Shen S, Rinaudo PF, Huddleston HG, McCulloch CE, Cedars MI. Fertilization rate is an independent predictor of implantation rate. Fertil Steril. 2010;94(4):1328-33. doi: 10.1016/j.fertnstert.2009.05.024. [PubMed: 19560757].
  • 6. Ferraretti AP, La Marca A, Fauser BC, Tarlatzis B, Nargund G, Gianaroli L, et al. ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod. 2011;26(7):1616-24. doi: 10.1093/humrep/der092. [PubMed: 21505041].
  • 7. Aflatoonian A, Eftekhar M, Mohammadian F, Yousefnejad F. Outcome of assisted reproductive technology in women aged 40 years and older. Iran J Reprod Med. 2011;9(4):281-4. [PubMed: 26396576]. [PubMed Central: PMC4576428].
  • 8. Moaddab A, Chervenak FA, McCullough LB, Sangi-Haghpeykar H, Shamshirsaz AA, Schutt A, et al. Effect of advanced maternal age on maternal and neonatal outcomes in assisted reproductive technology pregnancies. Eur J Obstet Gynecol Reprod Biol. 2017;216:178-83. doi: 10.1016/j.ejogrb.2017.07.029. [PubMed: 28783553].
  • 9. Allow AKN, Abdulmogny A, Bracamonte M, Mohammad W. The relationship between duration of infertility and intrauterine insemination: a multi-centers study. J Clin Dev Biol. 2016;1(3):3-13.
  • 10. Gu L, Zhang H, Yin L, Bu Z, Zhu G. Effect of male age on the outcome of in vitro fertilization: oocyte donation as a model. J Assist Reprod Genet. 2012;29(4):331-4. doi: 10.1007/s10815-012-9719-9. [PubMed: 22318293]. [PubMed Central: PMC3309984].
  • 11. Whitcomb BW, Turzanski-Fortner R, Richter KS, Kipersztok S, Stillman RJ, Levy MJ, et al. Contribution of male age to outcomes in assisted reproductive technologies. Fertil Steril. 2011;95(1):147-51. doi: 10.1016/j.fertnstert.2010.06.039. [PubMed: 20663496]. [PubMed Central: PMC2998574].
  • 12. Duran EH, Dowling-Lacey D, Bocca S, Stadtmauer L, Oehninger S. Impact of male age on the outcome of assisted reproductive technology cycles using donor oocytes. Reprod Biomed Online. 2010;20(6):848-56. doi: 10.1016/j.rbmo.2010.03.005. [PubMed: 20378414].
  • 13. Weissman AHC. Tretament strategies in assisted reproduction for the poor responder patient. In: Gardner DK, Weissman A, Howles CM, Shoham ZV, editors. Textbook of Assisted Reproductive Techniques Fourth Edition: Volume 2: Clinical Perspectives. 2. 2012. p. 162-207.
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments